类姜黄素-芳基钌配合物的合成、结构和光照激活抗癌活性

合成了3种含姜黄素衍生物(L¹~L³)和1,3,5-三氮杂-7-磷金刚烷(PTA)配体的芳基钌配合物[(η⁶-p-cymene)Ru(L)(PTA)]PF6(1~3,L=L¹~L³),通过X射线单晶衍射、核磁共振波谱、高分辨质谱、元素分析等方法表征了这些配合物的结构,并用MTT法研究了它们在λ>400 nm的光照辅助下对Hep G2人肝癌细胞的增殖抑制活性。结果表明,这3个配合物均为半三明治型结构;光辅助下,配合物抗癌活性明显提高,其中配合物3对HepG2细胞的IC50值从(60.3±1.1)μmol·L^-1降低至(45.0±6.1)μmol·L^-1。说明光照可以有效提高此类配合物的抗肿瘤活性。     

类姜黄素-芳基钌配合物的合成、结构和光照激活抗癌活性

合成了3种含姜黄素衍生物（L¹~L³）和1,3,5-三氮杂-7-磷金刚烷（PTA）配体的芳基钌配合物[（η⁶-p-cymene）Ru（L）（PTA）]PF₆（1~3,L=L¹~L³）,通过X射线单晶衍射、核磁共振波谱、高分辨质谱、元素分析等方法表征了这些配合物的结构,并用MTT法研究了它们在λ>400 nm的光照辅助下对HepG2人肝癌细胞的增殖抑制活性。结果表明,这3个配合物均为半三明治型结构;光辅助下,配合物抗癌活性明显提高,其中配合物3对HepG2细胞的IC₅₀值从（60.3±1.1）μmol·L^-1降低至（45.0±6.1）μmol·L^-1。说明光照可以有效提高此类配合物的抗肿瘤活性。     

联吡啶衍生物芳基钌配合物的合成及其与DNA、蛋白质相互作用

以2种配体4,4′-dimethyl-2,2′-bipyridine(L1)和4′-methyl-(2,2′-bipyridine)-4-carbaldehyde oxime(L2),分别与芳基钌二聚体[RuCl_2(η~6-p-cymene)]2合成了2种新型单核配合物[Ru(η~6-p-cymene)(L1)Cl]Cl(1)和[Ru(η6-p-cymene)(L2)Cl]Cl(2)。应用元素分析、ESI-MS和~1H NMR对配合物的组成和结构进行表征,通过紫外光谱法和荧光光谱法研究了配合物的水解及其与CT-DNA和血清蛋白的结合性质,并且进行了细胞毒性研究。结果表明,在水溶液中配合物1比2在动力学上更稳定(k:0.383 h~(-1)(1)、1.458 h~(-1)(2));配合物均通过嵌入作用与双链DNA结合,但2有较强的结合能力(Kb:7.8×10~3L·mol~(-1)(1)、1.86×10~4L·mol~(-1)(2))。配合物均能与蛋白质发生相互作用,引起蛋白静态猝灭,但1作用较强(KA:1.04×10~5L·mol~(-1)(1)、8.62×10~4L·mol~(-1)(2))。配合物与蛋白的较强结合能力,可能是其细胞毒性不高的原因。     

靶向DNA的刚性配体的双核芳基钌配合物（英文）

以刚性配体1,3-bib(1,3-二(1H-咪唑-1-基)苯)与[Ru(η6-p-bip)Cl2]2(p-bip,联苯基团)为原料,合成了3种双核芳基钌配合物[Ru_2(η~6-p-bip)_2(1,3-bib)_2XY]X_2(X=Y=Cl-(1),X=Y=Br-(2),X=I-和Y=Cl-(3),并用核磁和质谱等对配合物进行了表征。配合物1的单晶衍射结果表明其具有一种刚性双核M2L2碗状结构,空腔中心有一个阴离子Cl-。配合物3对A549细胞有较高的抗癌活性(IC50=13.9μmol·L-1),与顺铂细胞毒性(IC50=15.2μmol·L-1)相当。紫外吸收光谱、圆二色谱、凝胶电泳法研究表明配合物1～3与DNA发生强烈的相互作用并且诱发DNA发生解旋。     

基于对异丙基甲苯和二甲基双胍的对称双核钌(Ⅱ)配合物的合成及其体外抗癌活性

在碱性水溶液中合成了一种对称双核桥联配合物(NH4)2[Ru(Cym)(L)]2C12·4H2O(1)(Cym=对异丙基甲苯,H2L=1,1-二甲基双胍).采用红外光谱、核磁共振谱和X射线单晶衍射进行了结构表征,结晶水数目由热重分析法得出.采用MTT法测定了其对4种人癌细胞系HepG-2、A549、Hela、MCF-7...     

不同配体对钌多吡啶配合物与DNA的作用和荧光性质的影响

Two polypyridyl ligands DCHIP (2-hydro-3，5-dichlorophenyl-imidazo[4，5-f][1，10] phenanthroline)，MDHIP(2，4-dihydrophenyl-imidazo[4，5-f][1，10]phenanthroline) and their ruthenium(Ⅱ) complexes [Ru(phen)₂MDHIP]²⁺ and [Ru(phen)₂DCHIP]²⁺ were prepared. Their DNA-binding properties were studied by spectroscopic methods and viscosity measurements. The results indicated that the complexes both bound to DNA by partial intercalation mode， but [Ru(phen)₂DCHIP]²⁺ exhibited stronger binding affinity for DNA than [Ru(phen)₂MDHIP]²⁺ due to the different planarities and steric effects of ligands. On the other hand， after binding to DNA， the fluorescence intensity of [Ru(phen)₂MDHIP]²⁺ decreased， while the fluorescence intensity of [Ru(phen)₂ DCHIP]²⁺ increased.     

单核锇配合物的合成、晶体结构及其与DNA的作用

使用溶剂热合成法,以p-bitmb配体(1,4-二(1-咪唑基-亚甲基)-2,3,5,6-四甲基苯)与[(η6-cymene)Os(μ-Cl)Cl]2或[(η6-bip)Os(μ-Cl)Cl]2为原料,合成了2种单核芳基锇配合物,并利用核磁、质谱、元素分析和X射线单晶衍射等手段对配合物进行了表征。配合物1属于单斜晶系,P21/c空间群,为一个单核锇的结构。中心锇原子与2个配体p-bitmb上的氮原子以及氯原子进行配位,2个配体的另一个咪唑基团通过一个亚甲基碳原子进行连接形成咪唑嗡离子,形成一个类似"碗"状的结构。一个氯离子通过氢键装载在结构的空腔内。利用核磁共振氢谱研究了结构中亚甲基的来源,并研究了配合物在缓冲溶液中的稳定性。用紫外吸收光谱、圆二色谱以及粘度法研究了配合物与DNA的相互作用,结果表明,配合物中的亚甲基来自于溶剂二氯甲烷。配合物以嵌入的方式与CT-DNA相互作用,结合常数分别为3.222×10~4 L·mol-1 (1)和1.53×10~4 L·mol-1 (2),同时配合物会减弱DNA的碱基堆积作用并可以使DNA发生解旋。     

钌配合物断裂DNA及其机理研究

DNA是遗传信息的携带者和基因表达的物质基础,金属配合物与DNA的相互作用研究受到广泛关注,成为生物无机化学的重要研究内容之一.与其他类型金属配合物相比,钌配合物具有良好的热力学稳定性以及丰富的光化学、光物理和氧化还原特性,其作为DNA断裂试剂也引起人们的极大兴趣.以近年一些代表性的研究工作为例,本文对钌配合物在DNA断裂作用机制方面的研究进展进行了综述.     

烷氧基三联吡啶钌配合物的合成、结构及其与DNA相互作用

制备了2种含长基链的烷氧基三联吡啶和2,2''-联吡啶配位的钌配合物（Ru-Cl、Ru-NCMe）,通过质谱、核磁和单晶X射线衍射分析等进行了表征。从它们的晶体结构可以发现Ru-Cl配合物中第6个配位点为Cl-离子,在Ru-NCMe配合物中的第6个配位点为乙腈分子中的N原子。通过紫外可见吸收光谱和荧光光谱研究了这2种配合物与多种氨基酸和DNA的作用,发现这种长烷基链和刚性配位平面的配合物与DNA具有明显的特异性识别效应,进一步研究发现它们与DNA以插入方式和静电作用结合,实验与理论模拟结果一致。     

手性双核钌(Ⅱ)配合物与DNA的相互作用研究

本文合成了1对手性双核钌(Ⅱ)配合物ΔΔ-和ΛΛ-[(bpy)₂Ru(mbpibH₂)Ru(bpy)₂](ClO₄)₄(bpy=2,2′-联吡啶,mbpibH₂=1,3-二(咪唑并[4,5-f][1,10-邻菲咯啉])苯)。通过元素分析、质谱、核磁共振、CD光谱对这两个化合物进行了结构表征。采用循环伏安法对配合物的电化学性质进行了分析。利用紫外-可见吸收光谱滴定、荧光光谱滴定     

抗肿瘤多核铂配合物的研究

多核铂配合物作为非经典铂抗肿瘤药物,其抗肿瘤机制与现有铂类抗肿瘤药物不同,因而在克服现有铂类抗肿瘤药物耐药性方面有着巨大的潜力。本文综述了多核铂类抗肿瘤药物的研究进展,以连接铂原子的桥配体结构的不同,可分为六大类:以烷基二胺及其衍生物为桥的多核铂配合物、以含氮杂环为桥的多核铂配合物、以羧酸根为桥的多核铂配合物、以卤素离子为桥的多核铂配合物、以含硫配体为桥的多核铂配合物及以其他配体为桥的多核铂配合物。本文还介绍了这几类多核铂配合物的抗肿瘤机理及在克服顺铂耐药性机理方面的研究进展。     

Antimicrobial and Anticancer Application of Silver(I) Dipeptide Complexes

Three silver(I) dipeptide complexes [Ag(GlyGly)]_n(NO₃)_n (AgGlyGly), [Ag₂(GlyAla)(NO₃)₂]_n (AgGlyAla) and [Ag₂(HGlyAsp)(NO₃)]_n (AgGlyAsp) were prepared, investigated and characterized by vibrational spectroscopy (mid-IR), elemental and thermogravimetric analysis and mass spectrometry. For AgGlyGly, X-ray crystallography was also performed. Their stability in biological testing media was verified by time-dependent NMR measurements. Their in vitro antimicrobial activity was evaluated against selected pathogenic microorganisms. Moreover, the influence of silver(I) dipeptide complexes on microbial film formation was described. Further, the cytotoxicity of the complexes against selected cancer cells (BLM, MDA-MB-231, HeLa, HCT116, MCF-7 and Jurkat) and fibroblasts (BJ-5ta) using a colorimetric MTS assay was tested, and the selectivity index (SI) was identified. The mechanism of action of Ag(I) dipeptide complexes was elucidated and discussed by the study in terms of their binding affinity toward the CT DNA, the ability to cleave the DNA and the ability to influence numbers of cells within each cell cycle phase. The new silver(I) dipeptide complexes are able to bind into DNA by noncovalent interaction, and the topoisomerase I inhibition study showed that the studied complexes inhibit its activity at a concentration of 15 μM.     

Dinuclear copper(I) complexes of N-methylbenzothiazole-2-thione: synthesis,structures, antibacterial activity and DNA interaction

Three copper(I) halide complexes containing N-methylbenzothiazole-2-thione (mbtt) and triphenylphosphine (PPh₃) have been prepared and structurally characterized by X-ray single-crystal analysis. Copper(I) halide precursors [CuΧ(PPh₃)]₄ (X = Cl, Br, I) react with mbtt in 1 : 4 M ratio to give complexes of formula [CuΧ(mbtt)(PPh₃)]₂. Hereby, dimerization is achieved in case of copper(I) chloride and bromide via halide bridges, while copper(I) iodide gives the binuclear thione-S-bridged dimer. The new complexes show moderate in vitro antibacterial activity against certain bacterial strains. The interaction of the compounds with calf-thymus DNA was monitored via UV–vis spectroscopy, DNA-viscosity measurements and their competition with ethidium bromide for the DNA intercalation sites studied by fluorescence emission spectroscopy. Intercalation was revealed as the probable mode of binding.     

Synthesis and structure of a new ternary monocopper(II) complex containing mixed ligands of 2,2′‐diamino‐4,4′‐bithiazole and picrate: in vitro anticancer activity,molecular docking and reactivity towards DNA

A new ternary monocopper(II) complex with co‐ligands of 2,2′‐diamino‐4,4′‐bithiazole (dabt) and picrate (pic), namely [Cu(dabt)(pic)₂], has been synthesized and characterized using elemental analyses, molar conductance measurements, infrared and electronic spectral studies and single‐crystal X‐ray diffraction. The crystal structure analyses revealed that the copper(II) ion has a {CuN₂O₄} distorted octahedral coordination environment. The hydrogen bonding interactions contribute to a three‐dimensional supramolecular structure in the crystal. The reactivity towards herring sperm DNA showed that the copper(II) complex can interact with DNA in the mode of intercalation. The molecular docking of the complex with DNA sequence d(ACCGACGTCGGT)₂ demonstrated that the copper(II) complex is stabilized by hydrogen bonding interaction. The in vitro anticancer activities suggested that the copper(II) complex is active against selected tumor cell lines. The effects of the two co‐ligands in the copper(II) complex on DNA‐binding events and in vitro anticancer activity are preliminarily discussed. Copyright © 2016 John Wiley & Sons, Ltd.     

联咪唑镍、镉配合物的合成、晶体结构及其与DNA相互作用

分别通过水热法和室温挥发法合成了2,2'-联咪唑(H₂biim)镍、镉配合物([Ni(H₂biim)₃](phth)(phth,邻苯二甲酸根)(1)、[Cd(H₃biim)₂Cl₄](2)),并通过X射线单晶衍射、元素分析和红外等技术手段对它们进行了表征。 单晶X衍射结果表明,配合物1的配离子中心镍离子周围的配体以3个中性联咪唑分子形式分别进行二齿螯合配位,构成六配位的畸变八面体构型,邻苯二甲酸根离子在外界与配体形成丰富的氢键;而在配合物2中,两个联咪唑配体却以含有氢质子的阳离子H₃biim⁺形式与中心镉离子单齿配位,镉离子同时结合4个氯原子形成六配位配位环境。 通过紫外光谱、荧光光谱和黏度法测试结果表明配合物1和2分别与小牛胸腺DNA(ct-DNA)以经典插入和部分插入模式进行相互作用。     

Substitution‐Inert Polynuclear Platinum Complexes That Inhibit the Activity of DNA Polymerase in Triplex‐Forming Templates

The formation of triple‐helical DNA is implicated in the regulation of gene expression. The triplexes are, however, unstable under physiological conditions so that effective stabilizers for the triplex formation are needed. Herein, we describe a new strategy for the stabilization of such triplexes that is based on antitumor substitution‐inert polynuclear platinum complexes (SI‐PPCs). These compounds were previously shown to bind to DNA through the phosphate clamp—a discrete mode of DNA–ligand recognition distinct from the canonical intercalation and minor‐groove binding. We have found that SI‐PPCs efficiently inhibit DNA synthesis by DNA polymerase in sequences prone to the formation of pyrimidine‐ and purine‐motif triplex DNAs. Moreover, the results suggest that SI‐PPCs are able to induce the formation of triple‐helical DNA between duplexes and strands that are not completely complementary to each other. Collectively, these data provide evidence that SI‐PPCs are very efficient stabilizers of triple‐stranded DNA that might exert their action by stabilizing higher‐order structures such as triple‐helical DNA.     

大环多胺及其金属配合物与DNA的相互作用

本文综述了近年来基于大环多胺及其金属配合物与DNA相互作用的研究进展,着重介绍本课题组在有关单双核、多核以及功能化大环多胺衍生物及其金属配合物与DNA相互作用方面的研究和发现,并对其在化学核酸酶方面的应用进行了讨论。在单双核大环多胺衍生物方面,我们分别合成了以吡啶、苯环、咪唑、三氮唑为侧臂的单核大环多胺金属配合物,同时合成了以刚性桥相连的双核配合物和以柔性链相连的双核配合物。并研究这些单双核大环多胺与DNA的相互作用,发现以刚性链相连的双核大环多胺金属配合物具有很好的切割DNA的性质,可以在低浓度、短时间内切断DNA。在功能化大环多胺方面,我们合成了含有碱基、PNA单体、咪唑鎓盐、冠醚、二茂铁等功能化基团的大环多胺衍生物及金属配合物,并研究了其与DNA的相互作用。在多核大环多胺方面,我们合成了基于大环多胺的寡聚物,研究发现该类物质可与DNA形成复合物,从而有效地保护DNA免于酶解。